NEW YORK (GenomeWeb) – Drug discovery firm Selvita today said that it has formed a subsidiary called Ardigen to take over its bioinformatics business.

Ardigen's big data integration and analysis services business and custom application development operations will expand Selvita's bioinformatics services, Selvita said. Ardigen will form a new business unit focused on biological and clinical data analysis in genomics, transcriptomics, proteomics, metabolomics, and immunomics, and will also create a business unit around personalized medicine products and services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.